AG
MEDP icon

Ascent Group’s Medpace MEDP Stock Holding History

Ascent Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
20,413
+1,270
+7% +$586K 0.32% 73
2026
Q1 		$9.19M Buy
19,143
+756
+4% +$387K 0.32% 67
2025
Q4 		$10.3M Buy
18,387
+1,056
+6% +$599K 0.35% 57
2025
Q3 		$8.91M Buy
17,331
+513
+3% +$224K 0.32% 68
2025
Q2 		$5.28M Buy
16,818
+1,641
+11% +$493K 0.21% 102
2025
Q1 		$4.62M Buy
15,177
+5,803
+62% +$1.95M 0.2% 109
2024
Q4 		$3.11M Buy
9,374
+1,349
+17% +$457K 0.23% 106
2024
Q3 		$2.68M Buy
+8,025
New +$3.05M 0.2% 130

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ascent Group's MEDP Position: Q2 2026 in Review

Ascent Group increased its Medpace (MEDP) stake by 6.6% in Q2 2026, buying an estimated $586K and bringing the position to 20,413 shares worth $10.8M. The position accounts for 0.32% of the portfolio, ranked #73.

Ascent Group first reported a position in MEDP in Q3 2024 and has held it in 8 quarters since. 696 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Ascent Group held 20,413 shares of Medpace worth $10.8M as of Q2 2026.
  • Ascent Group bought 1,270 Medpace shares in Q2 2026, an estimated $586K.
  • Medpace made up 0.32% of Ascent Group's portfolio in Q2 2026, its #73 holding.
  • Ascent Group first reported a position in Medpace in Q3 2024 and has held it in 8 quarters since.
  • 696 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.